Immunitybio Inc share price logo

Immunitybio Inc

NASDAQ: IBRX

Mid Cap

$8.15

+0.03

(+0.37%)

Live

as on

Immunitybio Inc Stock Performance

as on May 14, 2026 at 4:14 am IST

  • Day's Low

    Day's High

    $7.78
    $8.22
    downward going graph

    4.54%

    Downside

    0.86%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.95
    $12.43
    downward going graph

    76.07%

    Downside

    52.52%

    Upside

    downward going graph

Immunitybio Inc share price movements today

Previous Close
$8.12
Open
$8.00
Volume
6.7M
Day's Low - High
$7.78 - $8.22
52 Week Low - High
$1.95 - $12.43

Immunitybio Inc Historical Returns

1 Month Return
+ 11.23 %
3 Month Return
+ 36.59 %
1 Year Return
+ 223.51 %
3 Year Return
+ 256.14 %
5 Year Return
-43.85 %

Immunitybio Inc Stock Fundamentals & Key Indicators

Check Immunitybio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.5B

EPS (TTM)

-0.79

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-245.4M

Revenue (TTM)

141.0M

Profit Margin

0.00%

Return On Equity TTM

0.00%

Immunitybio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunitybio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$8.5B-43.85%NA0.00%
BUY$38.0B119.7%71.3912.55%
NA$32.7BNA71.448.94%
BUY$110.4B109.14%25.8435.51%
BUY$74.7B39.88%17.3929.65%

Stock Returns calculator for Immunitybio Inc Stock including INR - Dollar returns

The Immunitybio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Immunitybio Inc investment value today

Current value as on today

₹3,64,418

Returns

₹2,64,418

(+264.42%)

Returns from Immunitybio Inc Stock

₹2,24,701 (+224.7%)

Dollar Impact

₹39,716 (+39.72%)

Analyst Recommendation on Immunitybio Inc Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Immunitybio Inc. Average target price of $15.5

Immunitybio Inc Share Price Target

Get share price movements and forecasts by analysts on Immunitybio Inc.

What analysts predicted

47.42%UPSIDE

Target Price

$15.5

Current Price

$8.15

Analyzed by

8 Analysts

Target

$15.50

Immunitybio Inc target price $15.5, a slight upside of 47.42% compared to current price of $8.15. According to 8 analysts rating.

Indian Investors' Interest in Immunitybio Inc Stock

Investment in Immunitybio Inc Shares on INDmoney has dropped by -46.17% in the last 30 days, indicating reduced investment activity.

Time period: to

Change:-46.17% versus previous 30 day period

Search interest for Immunitybio Inc Stock has decreased by -26% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-26% versus previous 30 day period

Immunitybio Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
1
6
7
16
26
32
38
44
Gross Profit
0
0
1
6
7
16
26
27
34
43
Operating Income
-85
-95
-99
-80
-69
-64
-71
-55
-64
-69
EBITDA
-196
-97
-91
-41
-40
-97
-59
-35
-31
-65
Interest Expense
32
37
39
40
14
28
28
27
27
28
Depreciation
4
4
4
4
4
3
3
3
3
-
Income Before Tax
-233
-134
-134
-85
-59
-129
-92
-67
-62
-632
Income Tax Expense
0
0
-4
-
0
0
0
0
0
0
Net Income
-233
-134
-134
-85
-59
-129
-92
-67
-61
-632
Net Profit Margin
-167907.91%
-335272.50%
-12852.34%
-1404.01%
-783.40%
-784.92%
-350.26%
-209.77%
-161.80%
-1431.44%

Immunitybio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
0
0
0
0
14
113
Gross Profit
0
0
3
-8
0
0
0
0
14
112
Operating Income
-124
-99
-98
-66
-220
-330
-351
-362
-344
-256
EBITDA
-117
-90
-86
-56
-204
-320
-351
-478
-264
-223
Interest Expense
0
0
0
5
9
14
47
86
131
112
Depreciation
-
-
-
14
12
14
18
19
17
15
Income Before Tax
-121
-96
-96
-65
-226
-349
-417
-583
-413
-351
Income Tax Expense
0
0
0
0
-1
0
0
0
0
0
Net Income
-120
-96
-96
-65
-221
-346
-416
-583
-413
-351
Net Profit Margin
-274565.91%
-214273.33%
-204736.17%
-152997.67%
-36669.59%
-37129.55%
-173569.58%
-93761.41%
-2804.77%
-310.18%

Immunitybio Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-134
-134
-85
-59
-129
-92
-67
-61
-632
Operating Cash Flow
-106
-100
-98
-85
-85
-79
-68
-70
-75
Investing Cash Flow
-35
-51
65
9
4
-16
-181
43
-31
Financing Cash Flow
10
148
15
106
0
172
173
54
223
Change in Cash
-132
-2
-18
31
-82
76
-76
28
116

Immunitybio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-96
-96
-160
-224
-346
-416
-583
-413
-351
Operating Cash Flow
-48
-63
-152
-171
-274
-337
-366
-391
-304
Investing Cash Flow
99
57
18
-19
-84
27
-30
-12
-149
Financing Cash Flow
-34
0
114
150
505
233
558
281
400
Change in Cash
15
-7
-19
-40
146
-76
160
-121
-54

Global Institutional Holdings in Immunitybio Inc

Funds
Holdings
Renaissance Technologies Corp
0.12%
BlackRock Inc
2.44%
Millennium Management LLC
0.34%
Morgan Stanley - Brokerage Accounts
0.49%
Two Sigma Investments LLC
0.45%

Immunitybio Inc News & Key Events

  • img

    Today's Timeline - 25 March

    Wed, 05:53 PM

    -

    ImmunityBio shares fell over 21% after FDA warning on misleading promotional statements for Anktiva cancer drug.

    Wed, 09:00 PM

    -

    ImmunityBio reports 407% revenue growth but shares down 35.8% since last earnings report.

Insights on Immunitybio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 9 quarters, 40.0K → 44.20M (in $), with an average increase of 42.2% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IBRX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, IBRX stock has moved up by 306.0%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, IBRX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -61.94M → -632.78M (in $), with an average decrease of 921.5% per quarter

About Immunitybio Inc

ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors; and 3M-052, a synthetic TLR7/8 agonist and 3M-052 formulations and related technology. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeOne Medicines Ltd. It has license agreement with 3M Innovative Properties Company and Access to Advanced Health Institute. ImmunityBio, Inc. is based in San Diego, California.
OrganisationImmunitybio Inc
Headquarters3530 John Hopkins Court, San Diego, CA, United States, 92121
IndustryBiotechnology
CEOMr. Richard Gerald Adcock
E-voting on sharesClick here to vote

Key Management of Immunitybio Inc

Name

Title

Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., M.S., M.Sc.

Founder, Executive Chairman and Global Chief Scientific & Medical Officer

Mr. David C. Sachs

Chief Financial Officer

Ms. Regan J. Lauer

Chief Accounting Officer

Dr. Enrique Diloné Ph.D., RAC

Chief Technology Officer

Ms. Sarah Singleton

Chief Communications Officer & Head of Patient Advocacy

Ms. Emily Arison

Senior Vice President of Human Resources

Mr. Richard Gerald Adcock

President, CEO & Director

Dr. Barry J. Simon M.D.

Chief Corporate Affairs Officer & Director

Dr. Leonard S. Sender M.D.

Chief Medical Officer of Liquid Tumors & Cell Therapy

Dr. Sandeep K. Reddy M.D.

Chief Medical Officer

FAQs

What is Immunitybio Inc share price today?

Immunitybio Inc share price today is $8.15 as on . Immunitybio Inc share today touched a day high of $8.22 and a low of $7.78.

What is the 52 week high and 52 week low for Immunitybio Inc share?

Immunitybio Inc share touched a 52 week high of $12.43 on and a 52 week low of $1.95 on . Immunitybio Inc stock price today i.e. is trending at $8.15,which is 34.43% down from its 52 week high and 317.95% up from its 52 week low.

What is Immunitybio Inc's market capitalisation today?

Immunitybio Inc market capitalisation is $0.01T as on .

How to invest in Immunitybio Inc Stock (IBRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunitybio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunitybio Inc Shares that will get you 0.1840 shares as per Immunitybio Inc share price of $8.15 per share as on May 13, 2026 at 10:44 pm IST.

What is the minimum amount required to buy Immunitybio Inc Stock (IBRX) from India?

Indian investors can start investing in Immunitybio Inc (IBRX) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Immunitybio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Immunitybio Inc share’s latest price of $8.15 as on May 13, 2026 at 10:44 pm IST, you will get 1.2270 shares of Immunitybio Inc. Learn more about fractional shares .

What are the returns that Immunitybio Inc has given to Indian investors in the last 5 years?

Immunitybio Inc stock has given -43.85% share price returns and 29.72% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?